Tina Brennan

Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions

Christine M. Lovly, Abha A. Gupta, Doron Lipson et al. · Cancer Discovery · 2014 · 452 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Clinical next‐generation sequencing successfully applied to fine‐needle aspirations of pulmonary and pancreatic neoplasms

Geneva Young, Kai Wang, Jie He et al. · Cancer Cytopathology · 2013 · 123 citations

Medicine, Genetics, Oncology +14

Abstract 5706: A blood-based next-generation sequencing assay to determine tumor mutational burden (bTMB) is associated with benefit to an anti-PD-L1 inhibitor, atezolizumab

David Fabrizio, Daniel S. Lieber, Christine M. Malboeuf et al. · Cancer Research · 2018 · 39 citations

Medicine, Oncology, Pharmacology +17

Analytic validation of a next generation sequencing assay to identify tumor mutational burden from blood (bTMB) to support investigation of an anti-PD-L1 agent, atezolizumab, in a first line non-small cell lung cancer trial (BFAST)

David Fabrizio, Christine M. Malboeuf, Daniel S. Lieber et al. · Annals of Oncology · 2017 · 20 citations · Full text

Medicine, Oncology, Pharmacology +17